Lion Street Advisors, LLC Novartis Ag Transaction History

Lion Street Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	BUY	$92.52 - $104.91 $5,088 - $5,770	55 Added 1.94%	2,884 $291,000
Q1 2023 Apr 12, 2023	BUY	$80.03 - $92.81 $226,404 - $262,559	2,829 New	2,829 $260,000
Q2 2022 Jul 19, 2022	SELL	$80.52 - $93.75 $197,032 - $229,406	-2,447 Closed	0 $0
Q4 2021 Jan 20, 2022	BUY	$79.7 - $88.13 $195,025 - $215,654	2,447 New	2,447 $214,000
Q2 2020 Jul 20, 2020	SELL	$80.93 - $91.1 $14,000 - $15,760	-173 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$70.67 - $99.01 $12,225 - $17,128	173 New	173 $14,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Lion Street Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Lion Street Advisors, LLC with notifications on news.